Alpha Tau Medical (DRTS) Receivables - Other (2020 - 2025)
Alpha Tau Medical (DRTS) posted Receivables - Other of $36000.0 for Q4 2025, up 111.76% sequentially from $17000.0 in Q4 2024, and up 111.76% YoY from $17000.0 in Q4 2024.
Alpha Tau Medical (DRTS) Receivables - Other (2020 - 2025) Analysis & Trends
Alpha Tau Medical has reported Receivables - Other for 6 years, with the latest figure at $36000.0 in Q4 2025.
- Quarterly Receivables - Other rose 111.76% year-over-year to $36000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36000.0 (up 111.76% YoY) and the FY2025 annual result came in at $36000.0, up 111.76% from the prior year.
- Receivables - Other advanced to $36000.0 in Q4 2025 per DRTS's latest filing, from $17000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $36000.0 in Q4 2025 and troughed at $17000.0 in Q4 2024.
- A 5-year average of $25200.0 and a median of $22000.0 in 2021 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2021 and 2023: Receivables - Other jumped 340.0% in 2021, then plunged 40.62% in 2023.
- Over 5 years, Receivables - Other stood at $22000.0 in 2021, then jumped by 45.45% to $32000.0 in 2022, then slumped by 40.62% to $19000.0 in 2023, then slipped by 10.53% to $17000.0 in 2024, then soared by 111.76% to $36000.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $36000.0, $17000.0, and $19000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Dec 31, 2020 | 5,000.00 |